Company: KNRX
Filing Date: 2025-09-30
Form Type: 424B4
Source: 0001493152-25-016175
Chunk: 179

Company: KNOREX LTD.
Filing Date: 2025-09-30
Form: 424B4
Chunk 179
---
 Shares.

Representative’s Warrants

We have also agreed to grant the Representative or its designee the Representative’s Warrants covering up to an aggregate number of Class A Ordinary Shares equal to 5% of the total number of Class A Ordinary Shares sold in this offering. The Representative’s Warrants will have an exercise price per share equal to 125% of the initial public offering price of the Class A Ordinary Shares sold in this offering. The Representative’s Warrants and the Class A Ordinary Shares underlying the warrants have been deemed compensation by FINRA and will be non-exercisable for one hundred and eighty (180) days beginning on the date of commencement of sales of the Offering, pursuant to FINRA Rule 5110(e)(1) and will expire five (5) years after such date. The Representative and its affiliates or employees (or permitted assignees under FINRA Rule 5110(e)(1)) may not sell, transfer, assign, pledge, or hypothecate the Representative’s Warrants or the Class A Ordinary Shares underlying the Representative’s Warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the Representative’s Warrants or the underlying shares for a period of one hundred and eighty (180) days following the date of commencement of sales of the public offering except as permitted by FINRA Rule 5110(e)(2). The Representative and its affiliates or employees will also be entitled to a one-time demand registration of the sale of the shares underlying the Representative’s Warrants and unlimited “piggyback” registration rights, which shall terminate on the fifth anniversary of the commencement of sales of the Offering in accordance with FINRA Rule 5110(g)(8)(D).

We will bear all fees and expenses attendant to registering the Class A Ordinary Shares underlying the Representative’s Warrants, other than any underwriting commissions incurred and payable by the warrant holders. The Representative’s Warrants will provide for adjustment in the number and price of such warrants and the shares underlying such warrants in the event of recapitalization, merger, or other structural transaction to prevent mechanical dilution, as in compliance with FINRA Rule 5110. The warrant exercise price and/or underlying shares may also be adjusted for issuances of Class A Ordinary Shares at a price below the warrant exercise price.

No Public Market Pricing

Prior to this offering, there has been no public market for our securities in the U.S. and the public offering price for our Class A